Aplenzin (sanofi-aventis U.S. LLC)
Welcome to the PulseAid listing for the Aplenzin drug offered from sanofi-aventis U.S. LLC. This Aminoketone [EPC],Dopamine Uptake Inhibitors [MoA],Increased Dopamine Activity [PE],Increased Norepinephrine Activity [PE],Norepinephrine Uptake Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | sanofi-aventis U.S. LLC |
| NON-PROPRIETARY NAME: | bupropion hydrobromide |
| SUBSTANCE NAME: | BUPROPION HYDROBROMIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Aminoketone [EPC],Dopamine Uptake Inhibitors [MoA],Increased Dopamine Activity [PE],Increased Norepinephrine Activity [PE],Norepinephrine Uptake Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, EXTENDED RELEASE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2009-03-30 |
| END MARKETING DATE: | 0000-00-00 |
Aplenzin HUMAN PRESCRIPTION DRUG Details:
| Item Description | Aplenzin from sanofi-aventis U.S. LLC |
| LABELER NAME: | sanofi-aventis U.S. LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 522(mg/1) |
| START MARKETING DATE: | 2009-03-30 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0024-5812_c25bf565-8061-450a-9217-a7a280ee0424 |
| PRODUCT NDC: | 0024-5812 |
| APPLICATION NUMBER: | NDA022108 |
Other BUPROPION HYDROBROMIDE Pharmaceutical Manufacturers / Labelers:
